Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anthera Pharmaceuticals has reported net loss of $18.57m for the first quarter ended 31 March 2011, compared to $11.1m for the same period in 2010.
Subscribe to our email newsletter
The company’s loss from operations was $18.67m, compared to $6.47m for the same period last year.
Total operating expenses for the first quarter ended 31 March 2011 were $18.7m, as compared to $6.5m for the same period in 2010.
Anthera Pharmaceuticals is a biopharmaceutical company engaged in developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases.